Integrating PET/CT and correlative biomarkers for prospective evaluation of extramedullary disease in relapsed/refractory B-ALL: implications for CAR T-cell therapy.
Solter ML, Wang YJ, Li G, Haque F et al. • Journal for immunotherapy of cancer
(2026)
PMC
PMC Public Access (View-Only)
DOI:
10.1136/jitc-2026-016031
PMC: PMC13735266